Objective To systematically review studies examining risk factors for herpes zoster (HZ).
Methods We performed a literature search using PubMed, EMBASE, and Web of Science for …

Patients with diabetes often have more invasive infections, which may lead to an increase in
morbidity. The hyperglycaemic environment promotes immune dysfunction (such as the …

Objective Patients with rheumatoid arthritis (RA) are at increased risk of herpes zoster (HZ),
and the risk appears to be increased in patients treated with tofacitinib. The aim of this study …

This study investigated the safety and efficacy of mirogabalin, a novel, potent, selective
ligand of the a2d subunit of voltagedependent Ca21 channels, for the treatment of …

Background Upadacitinib (UPA) is an oral Janus kinase (JAK) inhibitor approved for the
treatment of rheumatoid arthritis (RA). JAK inhibitors have been associated with an …

Abstract Abstract Objective In the ZOE-50 (NCT01165177) and ZOE-70 (NCT01165229)
phase 3 clinical trials, the adjuvanted recombinant zoster vaccine (RZV) demonstrated≥ …

Introduction: Before vaccination, varicella zoster virus (VZV), which is endemic worldwide,
led to almost universal infection. This neurotropic virus persists lifelong by establishing …

Objectives Herpes zoster (HZ) is caused by reactivation of varicella-zoster virus which
remains latent in individuals after a varicella infection. It is expected that HZ will be more …

Background Estimate the incidence of herpes zoster (HZ), its complications and healthcare
utilization rates in adults (≥ 18-years-old) with a wide range of immunocompromised (IC) …

Accumulating evidence suggests that diabetes mellitus (DM) represents an important risk
factor for both herpes zoster and post-herpetic neuralgia. Moreover, post-herpetic neuralgia …